drugset / Trial / NCT03358082
Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo
RandomizedParallel-groupOpen-labelTreatment
Summary
The study will evaluate the effectiveness of Tacrolimus 0.03% ointment monotherapy in patients with vitiligo. Patients will be treated for 6 months and followed for 3 months after treatment. All types of vitiligo will be included.
Timeline
- Start
- 2017-10-01
- Primary completion
- 2018-12-01
- Completion
- 2019-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrocortisone | Other / unclassified | 1 % | Topical |
| Comparator | Tacrolimus | Small molecule | 0.03 % | Topical |